Cargando…

Development of an adenovirus vector vaccine platform for targeting dendritic cells

Adenoviral (Ad) vector vaccines represent one of the most promising modern vaccine platforms, and Ad vector vaccines are currently being investigated in human clinical trials for infectious disease and cancer. Our studies have shown that specific targeting of adenovirus to dendritic cells dramatical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Piyush K, Dmitriev, Igor P, Kashentseva, Elena A, Raes, Geert, Li, Lijin, Kim, Samuel W, Lu, Zhi-Hong, Arbeit, Jeffrey M, Fleming, Timothy P, Kaliberov, Sergey A, Goedegebuure, S Peter, Curiel, David T, Gillanders, William E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972836/ https://www.ncbi.nlm.nih.gov/pubmed/29242639 http://dx.doi.org/10.1038/s41417-017-0002-1

Ejemplares similares

Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation
por: Geng, Kexin, et al.
Publicado: (2023)

Targeted Adenoviral Vectors I: Transductional Targeting
por: Dmitriev, Igor P., et al.
Publicado: (2016)

Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
por: González-Pastor, Rebeca, et al.
Publicado: (2019)

Transcriptional Targeting of Primary and Metastatic Tumor Neovasculature by an Adenoviral Type 5 Roundabout4 Vector in Mice
por: Lu, Zhi Hong, et al.
Publicado: (2013)

Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface
por: Lu, Zhi Hong, et al.
Publicado: (2022)

Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
por: Wilkinson-Ryan, Ivy, et al.
Publicado: (2015)

A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting
por: Lu, Zhi Hong, et al.
Publicado: (2020)

CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen
por: Flatt, Justin W., et al.
Publicado: (2012)

Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer
por: Kuroki, Lindsay M., et al.
Publicado: (2017)

A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy
por: Hassan, Ahmed O., et al.
Publicado: (2019)

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus
por: Kaliberov, Sergey A., et al.
Publicado: (2014)

The myeloid binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting
por: Lu, Zhi Hong, et al.
Publicado: (2014)

Prolonged Prophylactic Protection from Botulism with a Single Adenovirus Treatment Promoting Serum Expression of a VHH-Based Antitoxin Protein
por: Mukherjee, Jean, et al.
Publicado: (2014)

Cancer vaccines: shared tumor antigens return to the spotlight
por: Li, Lijin, et al.
Publicado: (2020)

Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein
por: van Erp, Elisabeth A, et al.
Publicado: (2015)

Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology
por: Tatzel, Katharina, et al.
Publicado: (2016)

Erratum: Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology
por: Tatzel, Katharina, et al.
Publicado: (2016)

A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector
por: Lu, Zhi Hong, et al.
Publicado: (2017)

Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer
por: Ashshi, Ahmad Mohammad, et al.
Publicado: (2016)

Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients
por: Agarwal, Payal, et al.
Publicado: (2021)

Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector
por: Williams, Briana Jill, et al.
Publicado: (2012)

Retargeted adenoviruses for radiation-guided gene delivery
por: Kaliberov, S A, et al.
Publicado: (2016)

Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines
por: Li, Lijin, et al.
Publicado: (2011)

A Strategy for Adenovirus Vector Targeting with a Secreted Single Chain Antibody
por: Glasgow, Joel N., et al.
Publicado: (2009)

Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)

An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer
por: Kim, Julius W., et al.
Publicado: (2013)

A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine
por: Fonseca, Jairo Andres, et al.
Publicado: (2016)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

Efficient Gene Transduction by RGB‐fiber Modified Recombinant Adenovirus into Dendritic Cells
por: Asada‐Mikami, Rumiko, et al.
Publicado: (2001)

CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter
por: Bhatia, Shilpa, et al.
Publicado: (2016)

The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine
por: Sallard, Erwan, et al.
Publicado: (2023)

Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016)

Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016)

Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors
por: Bontkes, Hetty J., et al.
Publicado: (2005)

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Mendonça, Samir Andrade, et al.
Publicado: (2021)

Adenoviral targeting using genetically incorporated camelid single variable domains
por: Kaliberov, Sergey A., et al.
Publicado: (2014)

Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm
por: Aldhamen, Yasser Ali, et al.
Publicado: (2011)

Development of replication-competent adenovirus based vaccine vectors
por: Abbink, P, et al.
Publicado: (2012)

Development of nonhuman adenoviruses as vaccine vectors
por: Bangari, Dinesh S., et al.
Publicado: (2006)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bdj0bkgo3jre9hnfuglq9171h7